Actively Recruiting
An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
Led by AbbVie · Updated on 2025-05-29
250
Participants Needed
16
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is a neurological condition, which affects the brain. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to assess how safe and effective ABBV-951 is in treating participants with Parkinson's disease in real world setting. ABBV-951 is an approved drug being developed for the treatment of PD in Japan. Approximately 250 adult participants over 15 years with a diagnosis of PD who are prescribed ABBV-951 by their physicians will be enrolled in this study across Japan. Participants will receive ABBV-951 as prescribed their physician and followed for 52 weeks. There is expected to be no additional burden for participants in this trial. Study visits may be conducted on-site or virtually as per standard of care.
CONDITIONS
Official Title
An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with advanced Parkinson's disease (aPD).
- Prescribed ABBV-951 as per physician's decision according to approved label for aPD treatment.
- Provided informed consent or consent by legal representative if required by the hospital/clinic.
You will not qualify if you...
- Prior treatment with ABBV-951 for Parkinson's disease.
- Currently participating in interventional clinical trials.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
Saiseikai Matsuyama Hospital /ID# 276259
Matsuyama, Ehime, Japan, 791-8026
Actively Recruiting
2
National Hospital Organization Asahikawa Medical Center /ID# 269115
Asahikawa, Hokkaido, Japan, 070-0901
Actively Recruiting
3
Ryugasaki Saiseikai Hospital /ID# 264435
Ryūgasaki, Ibaraki, Japan, 305-0854
Actively Recruiting
4
University of Tsukuba Hospital /ID# 268353
Tsukuba, Ibaraki, Japan, 305-8576
Actively Recruiting
5
Okatsu Hospital /ID# 262781
Kagoshima, Kagoshima-ken, Japan, 890-0067
Actively Recruiting
6
University Hospital Kyoto Prefectural University of Medicine /ID# 267445
Kyoto, Kyoto, Japan, 602-8566
Actively Recruiting
7
Sendai Nishitaga National Hospital /ID# 268349
Sendai, Miyagi, Japan, 982-8555
Actively Recruiting
8
Fujimoto General Hospital /ID# 277287
Miyakonojo-shi, Miyazaki, Japan, 885-0055
Actively Recruiting
9
Shiga University of Medical Science Hospital /ID# 265637
Ōtsu, Shiga, Japan, 520-2192
Actively Recruiting
10
Dokkyo Medical University Hospital /ID# 269116
Mibu, Tochigi, Japan, 321-0293
Actively Recruiting
11
Juntendo University Hospital /ID# 264438
Bunkyo-ku, Tokyo, Japan, 113-8431
Actively Recruiting
12
Nitobe Memorial Nakano General Hospital /ID# 275668
Nakano-ku, Tokyo, Japan, 164-0011
Actively Recruiting
13
National Center of Neurology and Psychiatry - Kodaira /ID# 267372
Xiaoping City, Tokyo, Japan, 187-8551
Actively Recruiting
14
National Hospital Organization Utano Hospital /ID# 268350
Kyoto, Japan, 616-8255
Actively Recruiting
15
Okayama Neurology Clinic /ID# 269117
Okayama, Japan, 702-8005
Actively Recruiting
16
Municipal Toyonaka Hospital /ID# 271277
Toyonaka, Japan, 560-0055
Actively Recruiting
Research Team
A
AbbVie GK Clinical Trial Registration Desk
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here